MORRIS PLAINS, N.J., June 8, 2007 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Gerard G. Gorman, Senior Vice President, Finance and Business Development, and Chief Financial Officer, will provide a corporate overview at the 6th Annual Needham Biotechnology and Medical Technology Conference on June 13 and 14, 2007 in New York, NY. The presentation, scheduled on Thursday, June 14, 2007 at 8:00 a.m. Eastern Time, can be downloaded simultaneously at http://www.immunomedics.com/1aboutus/present.pdf.
